2168: Lower rates of influenza infection following 2 dose series of high-dose vaccination in plasma cell disorders: Results of a randomized, double-blind, placebo-controlled study

OBJECTIVES/SPECIFIC AIMS: (1) Evaluate safety of a novel influenza vaccination strategy in patients with plasma cell disorders. (2) Measure laboratory-confirmed influenza infection rates following a novel influenza vaccination strategy in patients with plasma cell disorders. (3) Evaluate clinical co...

Descripción completa

Detalles Bibliográficos
Autores principales: Branagan, Andrew, Duffy, Eamon, Parker, Terri, Seropian, Stuart, Foster, Connor, Zhang, Lin, Verma, Rakesh, Gan, Geliang, Zelterman, Daniel, Brandt, Debra, Kortmansky, Jeremy, Witt, David, Dhodapkar, Madhav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2018
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6799516/
http://dx.doi.org/10.1017/cts.2017.118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6799516/
http://dx.doi.org/10.1017/cts.2017.118

Ejemplares similares